Optimized Peptide Inhibits MDM2-p53 Interaction
Author Information
Author(s): Shiheido Hirokazu, Takashima Hideaki, Doi Nobuhide, Yanagawa Hiroshi
Primary Institution: Department of Biosciences and Informatics, Keio University, Yokohama, Japan
Hypothesis
Can mRNA display selection identify a potent peptide that inhibits the MDM2-p53 interaction?
Conclusion
The study identified an optimized peptide, MIP, that effectively inhibits the MDM2-p53 interaction and activates the p53 pathway.
Supporting Evidence
- The peptide MIP inhibited the MDM2-p53 interaction with an IC50 of 10 nM.
- MIP was found to be 29-fold more potent than the previously identified peptide DI.
- Expression of MIP in living cells activated the p53 pathway.
- MIP also inhibited tumor cell proliferation in a p53-dependent manner.
Takeaway
Researchers found a special peptide that can stop a bad protein from blocking a cancer-fighting protein, helping to fight cancer better.
Methodology
The study used mRNA display to select MDM2-binding peptides from large random peptide libraries in two stages.
Limitations
The study did not explore all possible sequences due to the limitations of the library size.
Statistical Information
P-Value
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website